-
European economies suffer from heatwave
-
Wole Soyinka university theatre: a talent factory for Nigeria and beyond
-
Hospitals overwhelmed as Europe heatwave shifts east
-
Climate change to blame for intensity of Europe heatwave: scientists
-
努莎·奧貝爾與迪特馬爾·沃伊德克:波茨坦如何辜負一名重度殘障幼兒
-
Venezuelan mother digs with bare hands for missing son
-
'Very strong' nuclear verification needed in Iran after war: IAEA head
-
Нуша Аубель и Дитмар Войдке: как Потсдам бросает на произвол судьбы малыша с тяжелой формой инвалидности
-
US lose 3-2 to Turkey after last-gasp strike
-
Turkey beat US 3-2 with last-gasp winner
-
Venezuelans search for survivors after quakes kill at least 235
-
Asian stocks suffer fresh rout as rollercoaster week draws to close
-
French teen in Singapore straw-licking case to enter plea
-
Japan coach hopes World Cup success can inspire Asian rivals
-
Red rocks yield coveted minerals in DR Congo
-
'Unbearable': tracking heat in one of New Delhi's poorest areas
-
Sony discontinues Japan sales of robot puppy 'aibo'
-
Sheinbaum and King Felipe VI use World Cup to mend diplomatic rift
-
Tunisia boss Renard has 'no regrets' despite World Cup flop
-
Viral bullying videos test Bhutan's digital transition
-
Asian stocks drop again as rollercoaster week draws to close
-
Venezuela races to search for survivors after quakes kill at least 235
-
Court battle plays out over Wimbledon tennis expansion plan
-
Attack on ship in Hormuz leads UN to halt evacuation plan for trapped sailors
-
List of worst World Cup performances
-
Yoon leads Women's PGA Championship, Korda satisfied with 'solid' start
-
NZ internal report warns of Chinese military forays in Pacific
-
Japan to play Brazil in World Cup knockouts after nervy Sweden draw
-
Dutch march into World Cup knockouts as group winners
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 26
-
Guardian Metal Resources PLC Announces Pilot Mountain PFS Update & Investor Presentation
-
Better to qualify this way, says Ecuador World Cup hero Plata
-
Ivory Coast see 'no limits' after reaching World Cup knockouts for first time
-
Advocaat 'proud' of Curacao as minnows exit World Cup
-
Germany committed 'tactical suicide', says Nagelsmann
-
Iglesias -- Spanish World Cup striker unafraid to speak out about injustice
-
Quake-hit Venezuela's hospitals care for children left alone
-
Anderson to join Man City from Forest for British record fee: reports
-
Cole grabs PGA Travelers lead with Scheffler one back
-
Ecuador upset Germany to reach World Cup last 32 as Curacao eliminated
-
De Silva century rescues Sri Lanka in first Test
-
Ecuador edge Germany to squeeze into World Cup last 32
-
Pepe steers Ivory Coast into World Cup last 32 as Curacao go home
-
Spain women's star Putellas to join London City Lionesses
-
WNBA suspends Thomas for fist to Clark's throat
-
England showing Premier League edge at World Cup: Eze
-
UK'S King Charles breaks precedent to reveal £30 mn paid in taxes since 2022
-
Nasdaq falls again on mixed day for US stocks, oil prices rise
-
Yoon grabs early Women's PGA Championship lead with Korda in hunt
-
France squad look to do grieving Deschamps proud in final World Cup group game
Lantern Pharma Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / July 25, 2025 / RedChip Companies will air an interview with Lantern Pharma Inc. (Nasdaq:LTRN) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 26, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Access the interview in its entirety at: https://www.redchip.com/assets/access/ltrn_access
In an exclusive interview, Panna Sharma, CEO of Lantern Pharma, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how Lantern is redefining oncology drug development through its proprietary AI platform, RADR®. Sharma highlights Lantern's clinical-stage programs (LP-300, LP-184, and LP-284) which address high-need indications such as NSCLC in never-smokers, DDR-deficient solid tumors, and aggressive lymphomas. He also shares how Lantern's capital-efficient AI-driven model, which has enabled 12 oncology programs in just two years at a fraction of traditional development costs, is driving rapid value creation. With multiple upcoming clinical readouts, an expanding AI-driven pipeline, and over 100 issued and pending patents, Lantern is positioned as a next-generation biotech innovator at the intersection of artificial intelligence and precision oncology.
LTRN is a client of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About Lantern Pharma
Lantern Pharma (NASDAQ:LTRN) is an AI-driven biotechnology company focused on accelerating and optimizing the discovery, development, and commercialization of cancer therapies. Its RADR® platform leverages artificial intelligence and machine learning to uncover novel therapeutic opportunities, accelerate drug development, and improve patient outcomes.
Please find more information at:
Website: www.lanternpharma.com
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
[email protected]
--END--
SOURCE: RedChip Companies, Inc. (Media Suite)
View the original press release on ACCESS Newswire
H.Romero--AT